Literature DB >> 20071183

Cyclic-AMP response element binding protein and tau are involved in the neuroprotective mechanisms of nerve growth factor during focal cerebral ischemia/reperfusion in rats.

Zheng-Hong Zhang1, Gang-Ming Xi, Wen-Chun Li, Hai-Yan Ling, Peng Qu, Xiu-Bin Fang.   

Abstract

Nerve growth factor (NGF) has protective and therapeutic effects after cerebral ischemic injury. However, its mechanism of action is not clear. We explored the protective mechanism of exogenous NGF on rat hippocampal neurons after focal cerebral ischemia/reperfusion. Changes were detected in the expression of cyclic-adenosine monophosphate (AMP) response element binding protein (CREB) messenger ribonucleic acid (mRNA), CREB protein, phosphorylated CREB, tau mRNA, total tau protein and the state of phosphorylation of tau protein at the serine 199/202 site. NGF treatment significantly increased the expression of CREB mRNA, CREB and phosphorylated CREB in the hippocampal CA1 region. NGF alleviated the level of phosphorylation of tau and the expression level of total tau. It is possible that the protective effect of NGF on the ischemic neuron was due to the activation of transcription and translation of CREB, the reduction in the level of phosphorylation of tau protein, and the activation of a series of signal pathways. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071183     DOI: 10.1016/j.jocn.2009.07.086

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  13 in total

1.  Variations in target gene expression and pathway profiles in the mouse hippocampus following treatment with different effective compounds for ischemia-reperfusion injury.

Authors:  Yinying Chen; Caixiu Zhou; Yanan Yu; Jun Liu; Zhiwei Jing; Aiping Lv; Fanyun Meng; Zhong Wang; Yongyan Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-24       Impact factor: 3.000

2.  Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia.

Authors:  Xiao Zhang; Ming Shi; Ruidong Ye; Wei Wang; Xuedong Liu; Guangyun Zhang; Junliang Han; Yunxia Zhang; Bing Wang; Jun Zhao; Juan Hui; Lize Xiong; Gang Zhao
Journal:  Neurochem Res       Date:  2014-05-03       Impact factor: 3.996

3.  Inhibition of neuron-specific CREB dephosphorylation is involved in propofol and ketamine-induced neuroprotection against cerebral ischemic injuries of mice.

Authors:  Luowa Shu; Tianzuo Li; Song Han; Fang Ji; Chuxiong Pan; Bingxi Zhang; Junfa Li
Journal:  Neurochem Res       Date:  2011-09-03       Impact factor: 3.996

4.  Delayed Therapeutic Administration of Melatonin Enhances Neuronal Survival Through AKT and MAPK Signaling Pathways Following Focal Brain Ischemia in Mice.

Authors:  Ulkan Kilic; Birsen Elibol; Ahmet Burak Caglayan; Mustafa Caglar Beker; Merve Beker; Burcugul Altug-Tasa; Omer Uysal; Bayram Yilmaz; Ertugrul Kilic
Journal:  J Mol Neurosci       Date:  2022-03-21       Impact factor: 3.444

5.  Tau and caspase 3 as targets for neuroprotection.

Authors:  Anat Idan-Feldman; Regina Ostritsky; Illana Gozes
Journal:  Int J Alzheimers Dis       Date:  2012-05-30

6.  Systemic revealing pharmacological signalling pathway networks in the hippocampus of ischaemia-reperfusion mice treated with baicalin.

Authors:  Haixia Li; Yingying Zhang; Yanan Yu; Bing Li; Yinying Chen; Hongli Wu; Jingtao Wang; Jun Li; Xingjiang Xiong; Qiongyong He; Jinzhou Tian; Zhong Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-17       Impact factor: 2.629

7.  Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells.

Authors:  N Bartolotti; D A Bennett; O Lazarov
Journal:  Mol Psychiatry       Date:  2016-08-02       Impact factor: 15.992

Review 8.  Nerve growth factor: from the early discoveries to the potential clinical use.

Authors:  Luigi Aloe; Maria Luisa Rocco; Patrizia Bianchi; Luigi Manni
Journal:  J Transl Med       Date:  2012-11-29       Impact factor: 5.531

Review 9.  Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?

Authors:  Zhong Ming Qian; Ya Ke
Journal:  Front Aging Neurosci       Date:  2014-08-19       Impact factor: 5.750

10.  Transcription factor changes following long term cerebral ischemia/reperfusion injury.

Authors:  Hongbo Zhang; Weijuan Gao; Tao Qian; Jinglong Tang; Jun Li
Journal:  Neural Regen Res       Date:  2013-04-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.